HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Arrowstreet Capital Limited Partnership

Arrowstreet Capital Limited Partnership decreased its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,519,837 shares of the company's stock after selling 32,127 shares during the quarter. HCA Healthcare makes up 0.6% of Arrowstreet Capital Limited Partnership's holdings, making the stock its 25th biggest position. Arrowstreet Capital Limited Partnership owned about 0.99% of HCA Healthcare worth $756,329,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Legacy Investment Solutions LLC purchased a new position in shares of HCA Healthcare in the third quarter valued at approximately $39,000. Whipplewood Advisors LLC purchased a new position in shares of HCA Healthcare during the 4th quarter worth approximately $31,000. Tidemark LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth $36,000. Activest Wealth Management boosted its position in HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after acquiring an additional 125 shares during the last quarter. Finally, Pinnacle Bancorp Inc. boosted its stake in HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after buying an additional 50 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Price Performance

HCA stock traded up $4.17 during midday trading on Thursday, reaching $351.20. The company had a trading volume of 694,306 shares, compared to its average volume of 1,347,297. The company has a market capitalization of $86.47 billion, a P/E ratio of 15.99, a P/E/G ratio of 1.10 and a beta of 1.68. The firm has a 50-day moving average price of $326.35 and a 200-day moving average price of $340.30. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

Remove Ads

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the firm earned $5.90 EPS. On average, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 31st. Shareholders of record on Monday, March 17th were given a dividend of $0.72 per share. The ex-dividend date of this dividend was Monday, March 17th. This is a positive change from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.82%. HCA Healthcare's payout ratio is 13.11%.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Barclays dropped their target price on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. Morgan Stanley cut their target price on HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating on the stock in a research note on Tuesday, December 17th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. Royal Bank of Canada lowered their target price on HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating on the stock in a research note on Monday, January 27th. Finally, JPMorgan Chase & Co. restated a "neutral" rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $385.67.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 1.30% of the stock is owned by insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.